• Birmingham
  • Bristol
  • Henleaze
  • London
  • Watford
+44 (0)117 925 2020
  • Business
  • Personal
  • About Us
  • Our People
  • Insights
  • Log in
header desktop background
+44 (0)117 925 2020
  • Business
  • Personal
  • About Us
  • Our People
  • Insights
  • Log in
header mobile background
header mobile background
All
Articles (1002)
Events (29)
News (54)
112 results for 'VWV'
  • HIGHER EDUCATION Adobestock 427267986
    • Articles

    CMA publishes updated guidance on collaboration between higher education providers

    13 Apr 2026

    The CMA has issued updated guidance clarifying how higher education providers can collaborate while remaining compliant with UK competition law.

    • Higher Education
    • Education
  • Adobestock 350831221
    • Articles

    Contractual controls - what they are and what it means

    14 Apr 2026

    The government has published draft Provision of Information (Contractual Controls) (Registered Land) Regulations 2026 ("the Regulations") demonstrating its intention to introduce a new transparency regime for “contractual controls” over registered land. 

    • Real Estate & Infrastructure
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    Manufacturing investment announcements paint exciting future for UK life sciences

    20 Apr 2026

    Three pharma manufacturing investments of over £80 million have dramatically boosted UK life sciences prospects. They support the Life Sciences Sector Plan, which looks to make the UK the number one life sciences economy in Europe by 2030 and third in the world by 2035. 

    • Pharmaceuticals & Life Sciences
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    Unlocking innovation for brain tumours

    05 May 2026

    The Brain Tumour Charity has released a powerful report that highlights the urgent need for innovation in brain tumour treatments. Brain tumours remain the leading cancer killer of children and adults under 40, yet the pace of progress in developing new treatments has been alarmingly slow. The report identifies critical barriers to innovation and offers eight actionable recommendations to address these challenges.

    • Pharmaceuticals & Life Sciences
  • RE Planning & Infrastructure Article Image
    • Articles

    Unlocking development sites: land appropriation explained

    08 May 2026

    Land appropriation is increasingly being used by local authorities and developers to unlock sites for development. In this article, we explain how the appropriation process works, the statutory framework behind it, and how Section 203 powers can assist where development is affected by private third-party rights.

    • Real Estate & Infrastructure
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    Operation Pangea XVIII: What the UK’s largest medicines seizure means for the Pharma Sector

    27 May 2026

    Over two million doses. £4.6 million. Just 14 days. The results from Operation Pangea XVIII are striking with important implications for businesses operating in the UK pharmaceutical supply chain.

    • Pharmaceuticals & Life Sciences
  • 1
  • ...
  • 14
  • 15
  • 16
  • ...
  • 19
Make an enquiryCall us

Business
  • Banking & Finance
  • Charities
  • Digital & Technology
  • Education
  • Government & Public Services
  • Healthcare
  • Pharmaceuticals & Life Sciences
  • Real Estate & Infrastructure
Personal
  • Contentious Probate
  • Court of Protection
  • Family
  • Personal Immigration
  • Personal Injury
  • Probate & Estate Management
  • Residential Conveyancing
  • Wills & Trusts
About us
  • Careers
  • Diversity & Inclusion
  • Awards & Accreditations
  • Responsible Business
Locations
  • Birmingham
  • Bristol
  • Henleaze
  • London
  • Watford
    • Sitemap
      Policies & Terms
      Pay Online
      Pricing Information
      Regulatory Matters
    • Facebook
    • X
    • LinkedIn
    • Instagram
    • www.youtube.com

    ©Veale Wasbrough Vizards LLP.
    All rights reserved.

    © Veale Wasbrough Vizards LLP. All rights reserved. VWV is a brand of Veale Wasbrough Vizards LLP, a limited liability partnership registered in England and Wales, registered number OC384033, registered office Narrow Quay House, Narrow Quay, Bristol BS1 4QA. A list of members may be inspected at the registered office. The term 'Partner' means a member of Veale Wasbrough Vizards LLP or a senior employee of equivalent standing. Veale Wasbrough Vizards LLP is authorised and regulated by the Solicitors Regulation Authority (SRA 597329). Offices in Birmingham, Bristol, London and Watford. A member of The Association of European Lawyers with representative offices throughout the EU & Central & Eastern Europe. VAT Registration number GB 172 8860 77.